Virtual
Search Dashboard

Virtual Meetings

Connecting issuers with opportunities to leverage our contacts within the investment community, was challenged in 2019 when our live events were paused. To ensure our issuer and investor communities could continue to meet safely we launched our Virtual Meeting Series.

By engaging with our investor community in a virtual 1:1 environment, issuers have curated access to building new relationships that lead to financings, open market support and increased awareness with top-tier capital market participants.

How it Works
This Week
View All
Issuer
Symbol
Market Cap
Sector
ProStar Holdings Inc.
TSXV: MAPS OTCPK: MAPPF
45.6M
Technology

ProStar® is a world leader in Precision Mapping Solutions®. ProStar’s flagship product, PointMan, is natively cloud and mobile and is offered as a Software as a Solution (SaaS). ProStar’s solutions seamlessly connects the field with the office and provides the ability to precisely capture, record, display, and manage critical infrastructure data in real-time, including roads, railways, pipelines, and utilities. ProStar’s solution has been adopted by some of the largest entities in North America, including Fortune 500 construction firms, subsurface utilities engineering (SUE) firms, utility owners, and government agencies.

ProStar has strategic business partnerships with the world’s leading geospatial technology providers, data collection equipment manufacturers, and their dealer networks, including Trimble®, Juniper® Systems, Bad Elf, Vivax-Metrotech, Radiodetection®, and Subsite® Electronics.

Purpose

Raise Awareness, Open Market Buying

Request a Meeting
Presentation One-Pager Visit Site
Delta 9 Cannabis Inc. New
TSX: DN OTCQX: DLTNF
38.513M
Cannabis

Delta 9 was founded in 2012 by father and son team, Bill and John Arbuthnot, and obtained a license to distribute medical cannabis in March 2014, becoming the 4th Licensed Producer of medical cannabis in Canada. After much preparation, Delta 9 became a publicly traded company on Monday, November 6th, 2017 trading as a Tier 2 Industrial Issuer on the TSX Venture Exchange originally under the stock ticker “NINE” but changed in July 2019 to ”DN”. Delta 9 graduated to the TSX main board on September 3, 2019.

Request a Meeting
Presentation One-Pager Visit Site
FRX Polymers New
Private
Private
Industrials

FRX Polymers is a disruptive growth company utilizing its patented green technology to manufacture flame retardant solutions that back a deep commitment to sustainability and the environment. Their products, sold under the brand name Nofia, are unique among flame retardant additives in that they are halogen-free, non-toxic, and non-leaching (permanent).

Note that the global supply chain for most goods is moving away from toxic products that contain halogen/bromine/chlorine, which has created a S$30 billion industry. FRX is in an unique position providing a green product where most of their competitors do not have a competing material, and their IP is protected by a portfolio of 200 patents worldwide.

Request a Meeting
Presentation One-Pager Visit Site
Real Luck Group Ltd. New
TSXV: LUCK OTCQB: LUKEF
16.5M
Esports

Real Luck Group Ltd (TSX.V: LUCK) is the parent company of Luckbox, a pure play esports betting company, that offers legal, real-money betting, live streams, and statistics on all major esports on desktop and mobile devices. Luckbox’s in-house customized user interface and user experience, built on a technology stack that supports multiple odds and streaming sources, allows the Company to deliver one of the world’s deepest esports betting coverage. In November 2020, Luckbox was named Rising Star at the EGR Operator Awards. As the Group is fully licensed in the Isle of Man for Business-to-Consumer (B2C) and Business-to-Business (B2B) esports & sports betting and casino, the Company has access to favourable payment processors.

Request a Meeting
Presentation One-Pager Visit Site
TRYP Therapeutics New
TSX: TRYP OTCMKTS: TRYPF
21.9M
Psychedelics

Tryp Therapeutics is leading the next wave of psychedelic drug development beyond mental health with its focus on chronic pain and other indications.  Tryp is on the cusp of initiating four Phase 2a clinical trials using synthetic psilocybin for fibromyalgia, phantom limb pain, complex regional pain syndrome (CRPS), and certain overeating disorders representing more than $12 billion in potential annual sales potential.  The company’s Scientific Advisory Board is chaired by Robin Carhart-Harris, one of the most prominent psychedelic researchers in the world. 

Purpose

Raise Awareness, Open Market Buying

Request a Meeting
Presentation One-Pager Visit Site
TUT Fitness Group Ltd.
TSX.V: GYM
8.0M
Fitness Technology

TUT Fitness Group is a Vancouver, Canadian based manufacturer of high-performance and affordable fitness products. We’ve designed a patented high performance (mass market ready) portable home gym (The TUT Trainer) that weighs less than 12 lbs, and that uses proprietary stackable resistance band plates (TUT Plates™) to replace bulky metal weights. We also sell a rowing cardio machine that leverages our resistance band technology, and that only weighs 21 lbs. 

Product 

At a combined 32 pounds (11.6 lbs. TUT Trainer & 21 lbs. Rower) and taking up less than 2 sq. feet, TUT’s flagship products, the TUT Trainer and TUT Rower, are more compact and affordable than other home gym alternatives (Peloton, Bowflex, Tonal etc.) providing a complete full body gym and cardio experience while assisting with form. Whether its functional strength training, prehab or rehab,  we think there is a tremendous opportunity to change the way people workout from home,  by giving them more value, higher performance and convenience in one solution,  with access to more than 250 exercises,  rather than forcing customers to pay more for multiple devices (pieces of equipment) that may or may not address their training needs.     

Purpose

Raise Awareness, Open Market Buying

Request a Meeting
Presentation One-Pager Visit Site
Appili Therapeutics Corp.
TSX: APLI OTCQX: APLIF
12M
Biotech

Appili Therapeutics is an infectious disease biopharmaceutical company that is purposefully built, portfolio-driven, and people-focused to fulfill its mission of solving life-threatening infections. By systematically identifying urgent infections with unmet needs, Appili’s goal is to strategically develop a pipeline of novel therapies to prevent deaths and improve lives. As part of  a  global  consortium,  Appili  is  sponsoring a Phase 3 clinical trial evaluating oral antiviral Avigan® / REEQONUSTM (favipiravir) for the worldwide treatment of COVID-19. The Company’s broader portfolio includes a broad-spectrum antifungal, a vaccine candidate to eliminate a serious biological weapon threat, and two antibiotic  programs.

,

Purpose

Raise Awareness, Open Market Buying

Request a Meeting
Presentation Visit Site
MustGrow Biologics Corp.
CSE: MGRO OTCQX: MGROF
208M
Biotech
  • A sustainable agriculture technology company that is providing a natural, organic crop protection platform with the potential to replace or complement synthetic chemicals.
  • Mustard seed-derived ingredients which are the natural defense mechanism of the mustard plant and can be used to protect crops from microbial diseases, pests and weeds.
  • Recently partnered with global trading powerhouse, Sumitomo Corporation, to fund and drive field development and regulatory work necessary for commercialization.

Purpose

Open Market Buying, Raise Awareness

Request a Meeting
Presentation One-Pager Visit Site
Avicanna Inc.
TSX: AVCN OTCQX: AVCNF
34.4M
Cannabis

Avicanna is a Canadian biopharmaceutical company providing the global marketplace with advanced natural cannabinoid solutions through an evidence-based approach offered across several product platforms including API, medical, pharmaceutical, and dermacosmetic. As a multinational organization with vertical integration, Avicanna is focused on utilizing the scientific research related to plant-derived cannabinoid products through its internal research platforms and strategic collaborations with world-class research institutions.

Purpose

Raise Awareness, Open Market Buying

Request a Meeting
Presentation One-Pager Visit Site
Testimonials

I was really impressed with the selection of companies and quality of opportunities presented. The format was well thought out and had the right mix of meetings with social participation.

Investment Advisor

Ascenta Finance Corp.

It has been a great week and doing the calls that you guys are setting up is a big part of the reason why we can’t wait to get to a live CEM conference again!

Saskatoon, SK

MustGrow Biologics Corp.

In this Covid-19 investment environment, like all investor relations professionals we are in constant need to find effective ways to connect with fresh-money buyers of our shares. The Virtual Series of meetings organized by Capital Event Management delivers! In our experience these virtual meetings have generally been “home runs”. They consistently deliver a buy-side audience of active small cap investors who are looking for new investment opportunities. The impact can be immediate. It has been time and money well invested by us.

Vancouver, BC

Reconnaissance Energy Africa Ltd.

It’s always great working with the CEM team, whether it’s at one of their conferences or taking part in the virtual investor meetings, they always conduct meaningful discussions with quality investors. Because of their significant network, they are able to add value by connecting us with relevant, long term investors.

Vancouver, BC

CloudMD Software & Services Inc.

Thanks to CEM, your team has done a good job of setting up meetings with knowledgeable cannabis investors.

Winnipeg, MB

Delta 9 Cannabis Inc.

Howard and his team at Capital Events have delivered tremendous value through their Virtual 1on1 Meeting package. After our calls, TAAL has experienced increased trading volume and continued follow up conversations with significant investors. Highly recommend this to any issuer.

Vancouver, BC

TAAL Distributed Information Technologies Inc.

How it Works
CEM’s Virtual Meeting Series operates under the same meeting guideline as our live events, but on your schedule and from the convenience of your home or office. You choose what time you can meet each week and we organize the rest!

These meetings bring proven results to both issuers and investors by exposing them to new opportunities with the convenience and flexibility of a virtual environment.
Learn More
Registration is now open for our 2022 Capital Event Series. Click here to register for an upcoming event!